title: Bevacizumab: not as good with more adverse reactions? Response.
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Martin
authors.forename: Maureen G
authors.initials: MG
authors.lastname: Maguire
authors.forename: Stuart L
authors.initials: SL
authors.lastname: Fine
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal